Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Chemotherapy and Targeted Drugs for Patients with Metastatic Colorectal Cancer

Autor: C. Qvortrup, Per Pfeiffer

Publikováno v: Multidisciplinary Treatment of Colorectal Cancer ISBN: 9783030588458
Pfeiffer, P & Qvortrup, C 2021, Chemotherapy and Targeted Drugs for Patients with Metastatic Colorectal Cancer . in G Baatrup (ed.), Multidisciplinary Treatment of Colorectal Cancer . Springer, pp. 187-202 . https://doi.org/10.1007/978-3-030-58846-5_21

Every year, almost 1.4 million new patients are diagnosed with colorectal cancer (CRC) worldwide, and more than 0.7 million patients will die due to the disease [1]. At the time of diagnosis, around 20% of the patients have synchronous metastases, bu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1f8e595fbf7d304649e366d05c39999
https://doi.org/10.1007/978-3-030-58846-5_21

Chemotherapy plus targeted drugs in conversion therapy for potentially resectable colorectal liver metastases: a meta-analysis

Autor: Qianqian Yu, Xianglin Yuan, Yinan Sun, Huixian Zhang, Lu Wang, Ben Zhao

Publikováno v: Oncotarget

// Lu Wang 1 , Yinan Sun 1 , Ben Zhao 1 , Huixian Zhang 1 , Qianqian Yu 1 and Xianglin Yuan 1 1 Department of Oncology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei Province, China Correspondence to: Xianglin Yuan, ema

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f93e6d47f4b394fdd9fd90013cbecb9
http://europepmc.org/articles/PMC5342449

Combination adjuvant chemotherapy with targeted drugs for treatment of colorectal cancer: A network meta-analysis

Autor: Dingxue Wang, Dongxin Tang, Bin Guo, Jun Li, Jinghui Wang, Li Luo, Yang Zhu

Publikováno v: Journal of cellular biochemistry. 119(2)

Colorectal cancer (CRC) is one of the most fatal diseases in the world. The efficacy of present chemotherapy treatments are limited and the addition of targeted drugs have been put into practice. However, the preferred treatments among adjuvant chemo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::866075cf4b3008e2b3bf7eddc3d20da4
https://pubmed.ncbi.nlm.nih.gov/28771807

Development of a UPLC–MS/MS method for simultaneous therapeutic drug monitoring of anti-hepatocellular carcinoma drugs and analgesics in human plasma

Autor: Shijia Lu, Mingming Zhao, Limei Zhao, Guofei Li

Publikováno v: Frontiers in Pharmacology, Vol 14 (2023)

In hepatocellular carcinoma treatment, sorafenib, oxaliplatin, 5-fluorouracil, capecitabine, lenvatinib, and donafenib are first-line drugs; regorafenib, apatinib, and cabozantinib are second-line drugs; and oxycodone, morphine, and fentanyl are comm

Externí odkaz: https://doaj.org/article/7e1889a1df3843ef990c59cc3e7d32c7